The effects of the cannabinoid receptor agonist Win 55,212-2 and of the com
petitive cannabinoid receptor antagonist SR 141716A on the electrically-evo
ked peristalsis of isolated distal colon of mouse were studied. Intralumina
l pressure, longitudinal displacement, ejected fluid volume and changes in
morphology of external intestinal wall were simultaneously recorded in the
pre-drug period and in presence of Win 55,212-2 alone or in combination wit
h SR 141716A, In the pre-drug pe riod (control), peristaltic activity was c
haracterised by regular, monophasic waves and the intraluminal content prop
elled towards anterograde (oro-aboral) direction with a propulsion velocity
of 1.25 +/- 0.1 mm X s(-1). Pressure and shortening waves showed a peak am
plitude of 2.43 +/- 0.32 kPa and 1.8 +/- 0.72 mm, respectively. The mean am
ount of fluid volume ejected during each contraction was 80 +/- 12.6 mul. T
he addition of Win 55,212-2 [10(-7)-10(-4) M] to the organ bath determined
a dose-related attenuation of peristaltic activity consequent to the decrea
se of circular and longitudinal muscle strength. The decrease of contractil
e activity was followed by dose-dependent decrease of the amount of fluid e
jected during peristalsis. The effects of Win 55,212-2 [10(-7)-10(-5) M] we
re prevented by SR 141716A, indicating the presence of cannabinoid CB1 rece
ptors in the mouse distal colon. SR 141716A alone enhanced both tonic and p
hasic motor activities in the colonic longitudinal smooth muscle, suggestin
g that CB1 receptor antagonists could act either through antagonising the e
ffect of endogenous CB1 receptor agonist or by an agonist effect on these r
eceptors, The present results further support the hypothesis that cannabino
ids perform a neuromodulatory role in various tracts of gastrointestinal sy
stem and first demonstrate their action also in the distal colon of rodents
. (C) 2001 Elsevier Science Inc. All rights reserved.